BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Butalbital; Aspirin; Caffeine; Codeine Phosphate.
Product ID | 63629-2952_0d4719d8-4e04-439d-953b-8cc5468619ca |
NDC | 63629-2952 |
Product Type | Human Prescription Drug |
Proprietary Name | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE |
Generic Name | Butalbital, Aspirin, Caffeine And Codeine Phosphate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2009-05-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA075231 |
Labeler Name | Bryant Ranch Prepack |
Substance Name | BUTALBITAL; ASPIRIN; CAFFEINE; CODEINE PHOSPHATE |
Active Ingredient Strength | 50 mg/1; mg/1; mg/1; mg/1 |
Pharm Classes | Barbiturates [CS],Barbiturate [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CIII |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2021-12-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA075231 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-05-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA075231 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-05-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA075231 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-05-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA075231 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA075231 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA075231 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-01 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
BUTALBITAL | 50 mg/1 |
SPL SET ID: | 95a33c9b-79a6-47c7-8433-fc217950b88f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
Pharm Class PE | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0527-1312 | Butalbital, Aspirin, Caffeine and Codeine Phosphate | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
0591-3546 | Butalbital, Aspirin, Caffeine and Codeine Phosphate | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
63629-2952 | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
69238-1993 | Butalbital, Aspirin, Caffeine and Codeine Phosphate | Butalbital, Aspirin, Caffeine and Codeine Phosphate |
51991-074 | Ascomp with Codeine | Butalbital, Aspirin, Caffeine and Codeine Phosphate |